ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026
The Cog-Aging: a 15-year cohort study of cognition in Brazilian older adults.
Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors.
Funding
Abstract
backgroundPrevalence of dementia is higher in low- and middle-income countries (LMICs). However, longitudinal studies characterizing cognitive decline and its clinical and epidemiological predictors remain scarce in Brazil.
methodsParticipants were enrolled from 2011 to 2025 and followed through May 2026. A total of 887 participants were classified as cognitively unimpaired (CU) (n = 274), mild cognitive impairment (MCI) (n = 378), or dementia of the Alzheimer's type (DAT) (n = 235). CU and MCI participants were followed until dementia conversion, which was analyzed under competing risks using cumulative incidence functions and Fine-Gray models.
resultsOverall, annualized dementia conversion rate in the MCI group was 10.72 per 100 person-years (95% confidence interval [CI]: 8.54% to 13.29%). In addition, 40.39% of participants progressed to dementia during a mean follow-up time of 3.75 years (standard deviation: 3.28), with an estimated cumulative incidence of 29.85% at 3 years (95% CI: 22.74% to 36.96%), accounting for death as a competing event. DISCUSSION: This study adds valuable information for LMICs. However, estimates should be interpreted considering attrition and competing mortality.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.